“allos-therapeutics” Archives

in
Entry Author Date Location
Amag Seeks New Chapter With $700M Cord Blood Registry Purchase 06/30/15 Boston
Hard-Nosed Hedge Fund Chief Has Soft Spot for Rare-Disease Startup 04/03/12 New York
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News 11/11/11 Boston
AMAG Shares Zoom on CEO Departure and Re-Org Plans 11/04/11 Boston
Celgene Pumps Up Acceleron, On-Q-ity CEO Goes to Roche Unit, MSMB Eyes Amag, & More Boston-Area Life Sciences News 08/05/11 Boston
New York Hedge Fund Makes $378 Million Bid for Amag in Attempt to Block Poorly Received Merger 08/03/11 Boston
Ksplice Bought By Oracle, Q2 Boston Deals Break $1B, General Catalyst Funds Airbnb, & More Boston-Area Deals News 07/27/11 Boston
Biogen Confirms Cambridge Move, Amag Merges With Allos, ACT Kicks Off Trials, & More Boston-Area Life Sciences News 07/22/11 Boston
Amag Makes Good on Acquisition Promise, But Wall Street Balks 07/20/11 Boston
Onyx Preps for Dash to FDA, After Myeloma Drug Helps Sickest of the Sick 07/26/10 San Francisco
The Pharmaceutical R&D Model is Broken. Here’s How to Fix It 03/05/10 Seattle
NormOxys Emerges from Stealth with New Class of Oxygen Drugs for Cancer, Heart Failure 12/04/09 Boston
Page 1 of 1